The economic crisis has negative effects on the pharmaceutical companies
as well. The Széll Kálmán Plan has a big impact on expenses, thus the
manufacturers need to rethink the marketing communications strategy on the home
market because of the price of the innovative products and the low levels of
public expenditures.
The base of innovation resides in exploitation of new approaches, new
opportunities and techniques. To accomplish business plans new approaches and techniques are
needed. More and more pharmaceutical companies choose the latest methods of
network research which can help to react better to the disasters of the
economic crisis. If we mix these type of researches, such as key opinion monitoring (KOL mapping) and the consumption
patterns of media, we can confront pharmaceutical product managers with really
interesting facts and patterns.
So the question is given:
How do the manufacturer and the distributor live with opportunities
given by network research?
The full interview with Péter
Ruppert and György Tímár, general managers of Maven7and Comfit is on view in
the medical journal, Medical Tribune.